Related Experiment Videos
Informed consent in the intensive care unit: ensuring understanding in a complex environment.
William Schweickert1, Jesse Hall
1Section of Pulmonary/Critical Care Medicine, University of Chicago Hospitals, Chicago, Illinois 60637, USA.
Current Opinion in Critical Care
|November 18, 2005
Summary
Obtaining informed consent in intensive care units (ICUs) is complex. Improving physician training and clear communication about research benefits can enhance patient understanding and decision-making quality.
Area of Science:
- Medical Ethics
- Critical Care Medicine
- Clinical Research
Background:
- Informed consent is crucial for critically ill patients facing complex treatment decisions.
- Research in intensive care units (ICUs) adds layers of complexity to informed consent processes.
- Patients and families require careful guidance through intricate medical choices.
Purpose of the Study:
- To review recent literature on informed consent challenges in the ICU.
- To identify obstacles and best practices for informed consent in critical care research.
- To provide guidance for physicians and researchers on ethical consent procedures.
Main Methods:
- Literature review of publications from the past year concerning ICU informed consent.
- Analysis of physician practices and training in informed consent communication.
- Evaluation of consensus statements and guidelines for critical care research.
Main Results:
- Physicians show varied understanding and training in informed consent.
- Therapeutic misconception is a common pitfall in communicating research goals.
- Extended discussion is the most effective method for improving informed consent quality.
- Existing consensus statements offer guidance for critical care research and consent procedures.
Conclusions:
- Standardizing indications and formalizing physician training enhance informed consent quality for critically ill patients.
- Researchers must address conflicts of interest and clearly communicate research risks and benefits.
- Patient safety is paramount; waiver of consent may be considered when research benefits significantly outweigh patient risk.